Enhancing Dendritic Cell Activation Through Manganese-Coated Nanovaccine Targeting the cGAS-STING Pathway

References

• Zhou J, Kroll A, Holay M, Fang R, Zhang L. Biomimetic nanotechnology toward personalized vaccines. Adv Mater. 2020;32(13):e1901255. doi:10.1002/adma.201901255
   PubMed Web of Science ®Google Scholar
• Dong H, Li Q, Zhang Y, Ding M, Teng Z, Mou Y. Biomaterials facilitating dendritic cell-mediated cancer immunotherapy. Adv Sci. 2023;10(18):e2301339. doi:10.1002/advs.202301339
   Web of Science ®Google Scholar
• Wang C, Ye Y, Hochu G, Sadeghifar H, Gu Z. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 2016;16(4):2334–2340. doi:10.1021/acs.nanolett.5b05030
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Chen J, Chen H, Hu C. Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation. Nanotheranostics. 2017;1(3):244–260. doi:10.7150/ntno.19796
   PubMedGoogle Scholar
• Voltà-Durán E, Parladé E, Serna N, Villaverde A, Vazquez E, Unzueta U. Endosomal escape for cell-targeted proteins. Going out after going in. Biotechnol Adv. 2023;63:108103. doi:10.1016/j.biotechadv.2023.108103
   PubMed Web of Science ®Google Scholar
• Li N, Zhang T, Wang R, et al. Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-β1 blockade. J Control Release. 2023;361:147–160. doi:10.1016/j.jconrel.2023.07.063
   PubMed Web of Science ®Google Scholar
• Yang X, Wei Y, Zheng L, et al. Polyethyleneimine-based immunoadjuvants for designing cancer vaccines. J Mat Chem B. 2022;10(40):8166–8180. doi:10.1039/d2tb01358
   PubMed Web of Science ®Google Scholar
• Shen X, Dirisala A, Toyoda M, et al. pH-responsive polyzwitterion covered nanocarriers for DNA delivery. J Control Release. 2023;360:928–939. doi:10.1016/j.jconrel.2023.07.038
   PubMed Web of Science ®Google Scholar
• Pang X, Liang S, Wang T, et al. Engineering thermo-pH dual responsive hydrogel for enhanced tumor accumulation, penetration, and chemo-protein combination therapy. Int j Nanomed. 2020;15:4739–4752. doi:10.2147/ijn.S253990
   PubMed Web of Science ®Google Scholar
• Alkhazaleh A, Elfagih S, Chakka L, et al. Development of proanthocyanidin-loaded mesoporous silica nanoparticles for improving dental adhesion. Mol Pharmaceut. 2022;19(12):4675–4684. doi:10.1021/acs.molpharmaceut.2c00728
   PubMed Web of Science ®Google Scholar
• Yu H, Liu Y, Zheng F, Chen W, Wei K. Erianin-loaded photo-responsive dendrimer mesoporous silica nanoparticles: exploration of a psoriasis treatment method. Molecules. 2022;27(19). doi:10.3390/molecules27196328
   Web of Science ®Google Scholar
• Figari G, Gonçalves J, Diogo H, Dionísio M, Farinha J, Viciosa M. Understanding fenofibrate release from bare and modified mesoporous silica nanoparticles. Pharmaceutics. 2023;15(6):1624. doi:10.3390/pharmaceutics15061624
   PubMed Web of Science ®Google Scholar
• He A, Li X, Dai Z, et al. Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy. J Nanobiotechnol. 2023;21(1):236. doi:10.1186/s12951-023-01989-x
   PubMed Web of Science ®Google Scholar
• Vanpouille-Box C, Hoffmann J, Galluzzi L. Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2019;18(11):845–867. doi:10.1038/s41573-019-0043-2
   PubMed Web of Science ®Google Scholar
• Qiao N, Wang H, Xu Y, et al. A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses. J Control Release. 2023;358:190–203. doi:10.1016/j.jconrel.2023.04.036
   PubMed Web of Science ®Google Scholar
• Gu Y, Lin S, Wu Y, et al. Targeting STING activation by antigen-inspired MnO nanovaccines optimizes tumor radiotherapy. Adv Healthcare Mater. 2023;12(12):e2300028. doi:10.1002/adhm.202300028
   Google Scholar
• Li J, Ren H, Qiu Q, et al. Manganese coordination micelles that activate stimulator of interferon genes and capture in situ tumor antigens for cancer metalloimmunotherapy. ACS Nano. 2022;16(10):16909–16923. doi:10.1021/acsnano.2c06926
   PubMedGoogle Scholar
• Li Q, Teng Z, Tao J, et al. Elastic nanovaccine enhances dendritic cell-mediated tumor immunotherapy. Small. 2022;18(32):e2201108. doi:10.1002/smll.202201108
   PubMed Web of Science ®Google Scholar
• Xu C, Dobson H, Yu M, et al. STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications. J Control Release. 2023;357:84–93. doi:10.1016/j.jconrel.2023.03.036
   PubMed Web of Science ®Google Scholar
• Nguyen T, Choi Y, Kim J. Mesoporous silica as a versatile platform for cancer immunotherapy. Adv Mater. 2019;31(34):e1803953. doi:10.1002/adma.201803953
   PubMed Web of Science ®Google Scholar
• Ejima H, Richardson J, Liang K, et al. One-step assembly of coordination complexes for versatile film and particle engineering. Science. 2013;341(6142):154–157. doi:10.1126/science.1237265
   PubMed Web of Science ®Google Scholar
• Chen J, Li J, Zhou J, et al. Metal-phenolic coatings as a platform to trigger endosomal escape of nanoparticles. ACS nano. 2019;13(10):11653–11664. doi:10.1021/acsnano.9b05521
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ma Z, Wang B, Guan Y, Su X, Jiang Z. Mn directly activates cGAS and structural analysis suggests Mn induces a noncanonical catalytic synthesis of 2ʹ3’-cGAMP. Cell Rep. 2020;32(7):108053. doi:10.1016/j.celrep.2020.108053
   PubMed Web of Science ®Google Scholar
• Zhang J, Fan B, Cao G, et al. Direct presentation of tumor-associated antigens to induce adaptive immunity by personalized dendritic cell-mimicking nanovaccines. Adv Mater. 2022;34(47):e2205950. doi:10.1002/adma.202205950
   PubMed Web of Science ®Google Scholar
• Tian D, Yang L, Wang S, et al. Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma. Nat Commun. 2019;10(1):4246. doi:10.1038/s41467-019-12243-0
   PubMedGoogle Scholar
• Picker L, Singh M, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995;86(4):1408–1419. doi:10.1182/blood.V86.4.1408.bloodjournal8641408
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Q, Ding M, et al. Endogenous/exogenous nanovaccines synergistically enhance dendritic cell-mediated tumor immunotherapy. Adv Healthcare Mater. 2023;12(17):e2203028. doi:10.1002/adhm.202203028
   Web of Science ®Google Scholar
• Zhang C, Dong Y, Gao J, Wang X, Jiang Y. Radial porous SiO2 nanoflowers potentiate the effect of antigen/adjuvant in antitumor immunotherapy. Front Chem Sci Eng. 2021;15(5):1296–1311. doi:10.1007/s11705-020-2034-6
   Web of Science ®Google Scholar
• Hao P, Peng B, Shan B-Q, Yang T-Q, Zhang K. Comprehensive understanding of the synthesis and formation mechanism of dendritic mesoporous silica nanospheres. Nanoscale Adv. 2020;2(5):1792–1810. doi:10.1039/D0NA00219D
   PubMed Web of Science ®Google Scholar
• Kim M, Kim J. Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration. RSC Adv. 2019;9(20):11230–11238. doi:10.1039/c9ra00818g
   PubMed Web of Science ®Google Scholar
• Luo M, Wang H, Wang Z, et al. A STING-activating nanovaccine for cancer immunotherapy. Nature Nanotechnol. 2017;12(7):648–654. doi:10.1038/nnano.2017.52
   PubMed Web of Science ®Google Scholar
• Edner NM, Carlesso G, Rush JS, Walker LSK. Targeting co-stimulatory molecules in autoimmune disease. Nat Rev Drug Discov. 2020;19(12):860–883. doi:10.1038/s41573-020-0081-9
   PubMed Web of Science ®Google Scholar
• Bonifaz L, Bonnyay D, Charalambous A, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 2004;199(6):815–824. doi:10.1084/jem.20032220
   PubMed Web of Science ®Google Scholar
• Barry M, Bleackley R. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2002;2(6):401–409. doi:10.1038/nri819
   PubMed Web of Science ®Google Scholar
• Kanaseki T, Shastri N. Biochemical analysis of naturally processed antigenic peptides presented by MHC class I molecules. In: van Endert P, editor. Antigen Processing: Methods and Protocols. Springer New York; 2019:101–108.
   Google Scholar
• Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9(4):271–285. doi:10.1038/nri2526
   PubMed Web of Science ®Google Scholar
• Schülke S. Induction of Interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front Immunol. 2018;9:455. doi:10.3389/fimmu.2018.00455
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu X, Hu Y, Chang M. A novel transcript isoform of TBK1 negatively regulates type I IFN production by promoting proteasomal degradation of TBK1 and lysosomal degradation of IRF3. Front Immunol. 2020;11:580864. doi:10.3389/fimmu.2020.580864
   PubMed Web of Science ®Google Scholar
• Yamashiro L, Wilson S, Morrison H, et al. Interferon-independent STING signaling promotes resistance to HSV-1 in vivo. Nat Commun. 2020;11(1):3382. doi:10.1038/s41467-020-17156-x
   PubMed Web of Science ®Google Scholar
• Mazewski C, Perez R, Fish E, Platanias L. Type I Interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways. Front Immunol. 2020;11:606456. doi:10.3389/fimmu.2020.606456
   PubMed Web of Science ®Google Scholar
• Ding H, Wang G, Yu Z, Sun H, Wang L. Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway. Biomed Pharmacother. 2022;155:113683. doi:10.1016/j.biopha.2022.113683
   PubMed Web of Science ®Google Scholar
• Zhou X, Su Q, Zhao H, Cao X, Yang Y, Xue W. Metal-phenolic network-encapsulated nanovaccine with pH and reduction dual responsiveness for enhanced cancer immunotherapy. Mol Pharmaceut. 2020;17(12):4603–4615. doi:10.1021/acs.molpharmaceut.0c00802
   PubMed Web of Science ®Google Scholar
• Marichal T, Ohata K, Bedoret D, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nature Med. 2011;17(8):996–1002. doi:10.1038/nm.2403
   PubMed Web of Science ®Google Scholar